Qrativ Company
.jpeg)
Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical.
(Reupload).png)
.png)
Technology:
Cancer
Industry:
Artificial Intelligence, Biotechnology, Drug Repurposing, Machine Learning, Pharmaceutical
Headquarters:
Greater Boston Area, East Coast, New England
Founded Date:
2017-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Total Funding:
8300000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2017
Last Funding Type:
Series A
Register and Claim Ownership